An announcement from Virax Biolabs Group Ltd. Class A ( ($VRAX) ) is now available. On December 3, 2025, Virax Biolabs Group Limited announced a ...

Advancements in omics-scale profiling technologies have ushered in new perspectives in immunology research and expanded our ...

HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.

The world’s first single-dose vaccine to prevent dengue fever has been approved for licensure in one of the largest countries ...

In a paper published in Trends in Immunology, scientists and doctors highlight the importance of studying long COVID in the ...

"There are some signs that another big norovirus season is ahead of us," Emory University Professor Ben Lopman told Newsweek.

Advisers to the Centers for Disease Control Prevention will scrutinize the childhood vaccine schedule and may start to upend ...

Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology research and diagnostics, announced today the ...

Pneumonia is a disease that burdens the health care system with more than 1.2 million emergency room visits each year and ...

Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today ...

A lawsuit from the AG's office accused Travis Broughton and his two stem cell companies of engaging in "false, misleading, ...

A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT, an immune checkpoint receptor ...